
Sera Prognostics Inc
NASDAQ:SERA

Intrinsic Value
The intrinsic value of one
SERA
stock under the Base Case scenario is
1.91
USD.
Compared to the current market price of 2.57 USD,
Sera Prognostics Inc
is
Overvalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sera Prognostics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Sera Prognostics Inc
Balance Sheet Decomposition
Sera Prognostics Inc
Current Assets | 47.6m |
Cash & Short-Term Investments | 46.2m |
Receivables | 53k |
Other Current Assets | 1.3m |
Non-Current Assets | 25m |
Long-Term Investments | 22m |
PP&E | 1.9m |
Intangibles | 1m |
Other Non-Current Assets | 124k |
Free Cash Flow Analysis
Sera Prognostics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Sera Prognostics Inc
Revenue
|
77k
USD
|
Cost of Revenue
|
-82k
USD
|
Gross Profit
|
-5k
USD
|
Operating Expenses
|
-36.6m
USD
|
Operating Income
|
-36.6m
USD
|
Other Expenses
|
3.7m
USD
|
Net Income
|
-32.9m
USD
|
SERA Profitability Score
Profitability Due Diligence
Sera Prognostics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Score
Sera Prognostics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
SERA Solvency Score
Solvency Due Diligence
Sera Prognostics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Sera Prognostics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SERA Price Targets Summary
Sera Prognostics Inc
Dividends
Current shareholder yield for SERA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SERA
stock under the Base Case scenario is
1.91
USD.
Compared to the current market price of 2.57 USD,
Sera Prognostics Inc
is
Overvalued by 26%.